| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $989.9M | +5.8% |
| Cost of Revenue | $406.8M | +2.7% |
| R&D Expense | $89.0M | +0.7% |
| SG&A Expense | $198.0M | +24.4% |
| Operating Income | $75.1M | +9.2% |
| Pre-tax Income | $75.3M | +20.4% |
| Income Tax | $29.8M | +12.1% |
| Net Income | $45.5M | +26.6% |
| EPS (Basic) | $1.29 |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $178.2M | +60.2% |
| Accounts Receivable | $112.6M | +18.3% |
| Current Assets | $338.6M | +32.3% |
| Total Assets | $1.36B | +3.6% |
| Current Liabilities | $628.4M | +0.5% |
| Long-term Debt | $116.6M | -2.5% |
| Total Liabilities | $774.9M | -2.0% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $166.7M | +410.6% |
| Capital Expenditures | $42.9M | -9.2% |
| Investing Cash Flow | -$47.8M | +71.2% |
| Financing Cash Flow | -$59.1M | -139.4% |
| Free Cash Flow | $123.8M | +950.0% |
| +26.5% |
| EPS (Diluted) | $1.25 | +23.8% |
| Stockholders' Equity |
| $581.0M |
| +12.1% |